With 26% Growth in H1, Neimeth Outshines Peers in Revenue Generation

Neimeth International Pharmaceuticals Plc emerged as the fastest-growing listed pharmaceutical company by revenue in the first half of 2026, recording a 26 per cent year-on-year increase in sales despite a challenging operating environment marked by high borrowing costs, inflationary pressures and foreign exchange volatility.

Raccontata dathisdaylive.com